I. Introduction
Pondera has discovered an innovative method to simultaneously reduce respiratory and emotional distress. We have unlocked the calming potential of cAMP-PDE4 inhibitors — for years, seen as the “holy grail” for respiratory and psychiatric disorders, but has been elusive until now.
By reducing both respiratory and emotional distress, there is a remarkable synergy, which reverses the vicious cycle between them.
Over the course of three decades, our team of neuroscientists have discovered the key to unleashing the pain-relieving potential of exogenous and endogenous opioids. Now we have transferred this innovative methodology to the next generation medication for respiratory and anxiety disorders.
Section II. Publications
Section III. ENDORPHINATE®: Natural nutraceutical formulations that promote relief from emotional and physical distress by enhancing healthy endorphin functioning: calm + well-being + mental clarity + energy.
Pondera Endorphinate® Overview
Section IV. Pondera Endorphinate Anxiety Relief Patent (February, 12 2013)
- A method to safely and effectively treat Anxiety conditions, symptoms and/or disorders in a subject in need comprising: (a) administering at least one Receptor Switcher to the subject, wherein the receptor switcher is N-acetyl cysteine; and (b) administering at least one Endorphin Enhancer to the subject, wherein the endorphin enhancer is a compound comprising caffeine.